A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
Clinical trial NCT01119859 · COMPLETED
Trial details
- NCT number
- NCT01119859
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-01-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.